Country Profile

Vanuatu

Vanuatu is a developing market for Indian pharmaceuticals — $1.23M in FY 2025–26. Medicines accounts for 93% of shipments, with vaccines contributing $68K.

🇻🇺 $1.23M · 1.0× growth since FY2015 · 0.2% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$1.23M
Exports FY2025–26 DGCIS
1.0×
Growth FY2015→2026
0.2%
CAGR FY2015→2026
93%
Medicines Share
3
Product Categories Supplied
Vanuatu is a developing market for Indian pharmaceuticals — $1.23M in FY 2025–26. Medicines accounts for 93% of shipments, with vaccines contributing $68K.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $1.14M (92.6%) Vaccines $68K (5.5%) Surgical & Hospital Supplies $23K (1.9%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Vanuatu in the RBI overseas direct investment dataset (2011–2026).